Stem cell transplantation during cancer
Authors: Pei-Ying Zhang
Xiao-Ying Zhang
Journal: Oncology Letters (2016)
Discipline: CLINICAL MEDICINE
Keywords: cancer; hematopoietic stem cell transplantation; mechanism; stem cell.
Affiliations: Nanjing University of Chinese Medicine, Information Institute, Nanjing, Jiangsu 221009, P.R. China., Department of Cardiology, Xuzhou Central Hospital, The Affiliated Xuzhou Hospital of Medical College of Southeast University, Xuzhou, Jiangsu 221009, P.R. China.

Abstract:  Hematological malignancies account for approximately 9.5% of new cancers diagnosed annually. Lymphoma is the most frequent of all known categories of hematological malignancies. Worldwide, extensive research has focused on this type of cancer. However, new treatments are investigated in various clinical as well as pre-clinical studies. Hematopoietic stem cell transplantation (HSCT) is a recent and upcoming treatment strategy for patients with hematopoietic malignancies and inborn errors of metabolism or immune deficiencies. Recent studies have revealed that successful clinical outcome of this treatment strategy depends on multiple factors including the protocol applied, disease under treatment, health of the patient, source of the grafts, severity of complications such as graft versus host disease during grafting and associated infections. The scope of this review is to achieve greater understanding of various clinical effects of the disease and related mechanisms. The electronic database Pubmed was searched for pre-clinical as well as clinical controlled trials reporting efficacy of the HSCT against hematological malignancies. 

Retracted: Yes

PubPeer comments:
 This review paper appears to be unexpectedly similar to a 2015 PhD thesis by Emma Watz at the Karolinska Institutet in Stockholm, called  Graft Viability and Transfusion Related Complications in Patients Undergoing Stem Cell Transplantations . That thesis can be found here: https: openarchive.ki.se xmlui bitstream handle 10616 44825 Thesis_Emma_Watz.pdf Here is a marked-up version of the text by Zhang and Zhang 2016, with highlighted text showing similarities to the Emma Watz 2015 thesis. Generated in SimTexter : ![file] ![file] ![file] , 
 2020 retraction. https: www.spandidos-publications.com 10.3892 ol.2020.12085 Following the publication of this article, an interested reader drew to our attention that the flow of the text, and the wording of numerous passages of text within the article, bore striking and unexpected similarities to the wording employed in a PhD thesis by Emma Watz at the Karolinska Institutet in Stockholm in 2015 entitled u201cGraft Viability and Transfusion Related Complications in Patients Undergoing Stem Cell Transplantationsu201d. After having conducted an internal investigation, the Editor of Oncology Letters has determined beyond all reasonable doubt that the review submitted to the Journal shared an unacceptable level of identity with the PhD thesis by Emma Watz. The authors were contacted about these apparent similarities between their review and the thesis, although they failed to respond to our query in this regard. The Editor of Oncology Letters deeply regrets that this article was not intercepted by our own checks for plagiarism prior to the publication of the review, and sincerely apologizes to the author of the PhD thesis and the readership for the inconvenience caused. We also thank the reader for bringing this matter to our attention. ,